After six years, IVI’s cholera control project in Mozambique concludes with 200,000 vaccine doses administered, stronger surveillance, and support for the National Cholera Plan.
Led by @DrSeEunPark with partners in Mozambique.
Read more: https://t.co/W3D6cVOoWY
Congratulations to the 2026 class of the IVI International Vaccinology Course!
Across Seoul, Kigali, and Stockholm, participants spent five days learning, collaborating, and building connections to carry into their work.
Here are a few voices from #IVC2026.
IVI congratulates our Board of Trustees Chairperson, Prof. Helen Rees, on receiving the NRF 2026 Lifetime Achievement Award.
Her leadership and commitment to health equity inspire our mission to make the benefits of vaccination available to everyone, everywhere.
Last night, the #NRFawards2026 honoured some of South Africa’s top researchers and scientists
Lifetime Achievers Professor Jonathan Jansen and Professor Hellen Rees headlined the event.
Read more here: https://t.co/TIjT9V1h64
Meet the 2026 IVI Vaccinology Fellows! 🌍
Each year, IVI supports promising vaccine professionals from low- and middle-income countries to join the International Vaccinology Course, share research, and build global connections.
Hear what fellows are taking from #IVC2026.
IVI welcomed 21 interns from around the world to our Seoul headquarters this summer.
Thank you for bringing your curiosity, ideas, and energy to our work in global health. We’re excited to see where your journeys take you next!
How do you approach finding a mentor?
At Careers in Vaccinology panels in Seoul, Kigali, and Stockholm, scientists and senior professionals shared career lessons, challenges, and opportunities with International Vaccinology Course participants.
IVI and Sweden’s @karolinskainst have signed an MoU to strengthen existing cooperation in vaccine research and education—and expand initiatives that translate innovation into better health outcomes worldwide.
Read more: https://t.co/OHSUgQ7igb
IVI is pleased to support 11 health professionals with government-funded scholarships to participate in #IVC2026.
With support from India, Thailand, and the Philippines, these scholarships strengthen expertise, knowledge exchange, and vaccine capacity where it matters most.
“Vaccines for a Connected World: A One Health Perspective” 🌍
Across Seoul, Kigali, and Stockholm, this year’s International Vaccinology Course explores how human, animal, and environmental health shape vaccinology, outbreak preparedness, and public health.
Leading experts from academia, industry, public health, and across the vaccine ecosystem make up the faculty of #IVC2026.
A few words of encouragement and insight from faculty across Seoul, Kigali, and Stockholm on vaccine hesitancy, advocacy, and vaccine development ⤵️
A safe and effective vaccine is only part of the challenge.
At the International Vaccinology Course, participants in Seoul, Kigali, and Stockholm are exploring vaccine hesitancy, barriers to uptake, and how communication can build trust in vaccination.
#IVC2026
IVI was proud to commemorate Malaysia’s accession to IVI at NICE 2026 in Kuala Lumpur. We look forward to deepening cooperation with Malaysia on vaccine research, development, innovation, and capacity strengthening.
🔗 https://t.co/HPkbGdqdaX
Murakaza neza. Välkommen. 환영합니다. Welcome!
IVI’s International Vaccinology Course begins today, celebrating its 25th anniversary.
Across Seoul, Kigali, and Stockholm, vaccine professionals explore the full spectrum of vaccinology.
🔗: https://t.co/tnzyuQ7dZy
IVI welcomes the opportunity to strengthen collaboration with Italy and the Fondazione Biotecnopolo di Siena in vaccine innovation, biotechnology, and pandemic preparedness.
Good discussions in Seoul on advancing cooperation among Italy, IVI, and Korea in vaccine innovation and global health.
At the Italian Embassy, I met Amb. Emilia Gatto and Prof. Rino Rappuoli of Fondazione Biotecnopolo di Siena, who later spoke at @IVIheadquarters on AMR.
What does GMP look like in practice? Gain hands-on experience applying GMP principles and MFDS regulatory requirements in a real biomanufacturing setting.
📅 September–November 2026
📍 Hwasun, Korea
⏰ Deadline: 28 Aug, 18:00 KST
🔗https://t.co/8VfQomUhzB
🇬🇧 During her visit to CISM on 14 August, Se Eun Park, from the @IVIHeadquarters, highlighted the CISM’s scientific capacity and the potential for future collaborations in vaccine research and development and capacity strengthening.
#CISM30#GlobalHealth
https://t.co/JVxmCH63gJ
IVI has appointed Prof. Faith Osier as inaugural Director of our newly established Kenya Country and AVEC Africa Project Office.
She will lead IVI’s work in Kenya and help advance end-to-end vaccine R&D across Africa through AVEC Africa.
Read more: https://t.co/U24owNM5Dz
From Bach and Mozart to Elgar, music took center stage at the 24th Lee Sang Hee & Friends Concert with IVI in Seoul.
The benefit concert also marked a milestone: KRW 1 billion in cumulative donations supporting IVI and other meaningful causes. Thanks to all who made it possible.
Chikungunya is a growing global health threat.
Dr. Anh Wartel of IVI shares how ACT-CHIK is advancing vaccine development and strengthening clinical research and manufacturing capacity in Africa.
Read more: https://t.co/fIKnJXGyzI
Congratulations and thanks to violinist Lee Sang Hee & Friends on their 24th annual benefit concert and reaching KRW 1 billion in donations benefiting IVI and other causes.
For 20+ years, they’ve shown how music can inspire generosity and advance global health through vaccines.